A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
Clinical trial NCT00637390 · TERMINATED
Trial details
- NCT number
- NCT00637390
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-10-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.